8-KThe WireStrategic
Material Agreement · Equity Issuance
Filed Apr 9, 2024 · 2y ago · Accession 0000950170-24-042789
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- 8-K
- Filing date
- Apr 9, 2024
- Report date
- Apr 8, 2024
- Document
- acrv-20240408.htm
- Size
- 1.2 MB